Management outcome of acute urinary retention: model of prediction.
AffiliationDepartment of Urology, Mercy University Hospital, University College Cork, Cork, , Ireland.
Adrenergic alpha-Antagonists/therapeutic use
Aged, 80 and over
Transurethral Resection of Prostate
MetadataShow full item record
CitationUrol Int. 2009;83(1):39-43. Epub 2009 Jul 27.
AbstractOBJECTIVES: To assess for predictors of outcome in patients presenting with acute urinary retention (AUR). METHODS: A study was performed in our unit to evaluate trial without catheter (TWOC) and successive management. We assessed for predictors of surgical or medical management, which included: age, volume drained at time of catheterisation, cause of retention, serum creatinine, success of trial of voiding, co-morbidities, prostate-specific antigen (PSA) and prostate size on digital rectal examination (DRE). RESULTS: 72 men were entered into the study over an 18-month period: 27 had a successful first TWOC, 20 patients had a second TWOC, and 6 were successful. In total, 31 of the 33 patients with a successful TWOC remained on alpha-blockers without a further episode of AUR within a minimum of 6 months' follow-up. Patients failing TWOC were managed by transurethral resection of the prostate (n = 22), long-term catheterisation (n = 15) or prostatic stents (n = 3), and 1 patient died prior to intervention. Three predictors were significant on multivariate analysis: PSA (>2.9 ng/ml), prostate size on DRE (large) and volume drained at time of catheterisation (>or=1,000 ml). CONCLUSION: Patients with elevated PSA (>2.9 ng/ml), a large prostate size on DRE and a volume drained at time of catheterisation >1,000 ml are best managed by surgical intervention, while those with volumes drained at time of catheterisation of <1,000 ml, a PSA
- Prostate size influences the outcome after presenting with acute urinary retention.
- Authors: McNeill AS, Rizvi S, Byrne DJ
- Issue date: 2004 Sep
- The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
- Authors: Desgrandchamps F, De La Taille A, Doublet JD, RetenFrance Study Group.
- Issue date: 2006 Apr
- Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
- Authors: McNeill SA, Hargreave TB, Roehrborn CG, Alfaur study group.
- Issue date: 2005 Jan
- Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
- Authors: Tiong HY, Tibung MJ, Macalalag M, Li MK, Consigliere D
- Issue date: 2009
- Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
- Authors: Kellner DS, Armenakas NA, Brodherson M, Heyman J, Fracchia JA
- Issue date: 2004 Oct